Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
|2||Active, not recruiting||
Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
Prevention of Ischemic Events in Patients With Peripheral Arterial Disease
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control
† Indicates status has not been verified in more than two years